The latest closing stock price for Protagonist Therapeutics as of June 25, 2025 is 54.44.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $3,653 today, roughly 4 times their original investment - a 18.63% compound annual growth rate over 9 years.
The all-time high Protagonist Therapeutics stock closing price was 59.76 on March 11, 2025.
The Protagonist Therapeutics 52-week high stock price is 60.60, which is 11.3% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 32.50, which is 40.3% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 43.28.
An investor who bought $1,000 worth of Protagonist Therapeutics stock at the IPO in 2016 would have $3,653 today, roughly 4 times their original investment - a 18.63% compound annual growth rate over 9 years.
The all-time high Protagonist Therapeutics stock closing price was 59.76 on March 11, 2025.
The Protagonist Therapeutics 52-week high stock price is 60.60, which is 11.3% above the current share price.
The Protagonist Therapeutics 52-week low stock price is 32.50, which is 40.3% below the current share price.
The average Protagonist Therapeutics stock price for the last 52 weeks is 43.28.